Medicinal, Psychological, and Health Research Journal (MPHRJ)

Effect of Intraoperative Intravenous Dexmedetomidine on Oxidative Stress in Patients Undergoing Cardiac Surgery: A Systematic Review

Document Type : Systematic Review

Authors

Solmaz Fakhari 1
Artin Bilehjani 2
Eissa Bilehjani 1

1 Professor of Anesthesiology, Department of Anesthesiology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

2 Medical student, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

https://doi.org/10.22034/mphrj.2026.586236.1092
Abstract
Introduction: Cardiac surgery is associated with substantial oxidative stress due to surgical trauma, cardiopulmonary bypass, and ischemia–reperfusion injury, which may contribute to postoperative organ dysfunction. Dexmedetomidine has shown potential antioxidative and organ-protective effects. Therefore, this study aimed to systematically review the effect of intraoperative intravenous dexmedetomidine on oxidative stress in patients undergoing cardiac surgery.

Material and methods: This systematic review followed PRISMA guidelines to identify clinical studies on intraoperative intravenous dexmedetomidine and oxidative stress in cardiac surgery. Multiple databases were searched without time limits by two independent reviewers using Boolean-based keywords. Eligible studies were screened, quality-assessed with the Cochrane Risk of Bias tool, and relevant study, patient, intervention, and outcome data were extracted.

Results: Across clinical and experimental cardiopulmonary bypass-related settings, intraoperative intravenous dexmedetomidine showed a broadly protective profile. It attenuated perioperative stress responses, reduced selected markers of myocardial injury and inflammation, improved hemodynamic and recovery outcomes, and lowered postoperative atrial fibrillation. Experimental evidence further indicated direct cardiomyocyte protection through antioxidant, antiapoptotic, autophagy-regulating, electrophysiological, and transcriptional mechanisms.

Conclusion: The available evidence suggests that intraoperative intravenous dexmedetomidine may mitigate oxidative stress-related injury during cardiac surgery through both systemic and cellular mechanisms. Its benefits appear to include attenuation of surgical stress, reduction of selected inflammatory and myocardial injury markers, and improvement in postoperative recovery. These findings support dexmedetomidine as a promising cardioprotective adjunct in cardiac surgical care.

Graphical Abstract

Effect of Intraoperative Intravenous Dexmedetomidine on Oxidative Stress in Patients Undergoing Cardiac Surgery: A Systematic Review

Keywords

Dexmedetomidine
Cardiac surgery
Oxidative stress
Cardiomyocyte protection
Systematic review
Subjects
[1] Featherstone, P. J., & Ball, C. M. (2018). The origins of cardiopulmonary bypass. Anaesthesia and Intensive Care, *46*(4), 351–353.
[2] Zakkar, M., Guida, G., Suleiman, M. S., & Angelini, G. D. (2015). Cardiopulmonary bypass and oxidative stress. Oxidative Medicine and Cellular Longevity, *2015*, Article 189863.
[3] Mauricio Del Rio, J., Nicoara, A., & Swaminathan, M. (2017). Neuroendocrine stress response: Implications for cardiac surgery-associated acute kidney injury. Romanian Journal of Anaesthesia and Intensive Care, *24*(1), 57–63.
[4] Gajarski, R. J., Stefanelli, C. B., Graziano, J. N., Kaciroti, N., Charpie, J. R., & Vazquez, D. (2010). Adrenocortical response in infants undergoing cardiac surgery with cardiopulmonary bypass and circulatory arrest. Pediatric Critical Care Medicine, *11*(1), 44–51.
[5] Winterhalter, M., Brandl, K., Rahe-Meyer, N., Osthaus, A., Hecker, H., Hagl, C., Adams, H. A., & Piepenbrock, S. (2008). Endocrine stress response and inflammatory activation during CABG surgery. A randomized trial comparing remifentanil infusion to intermittent fentanyl. European Journal of Anaesthesiology, *25*(4), 326–335.
[6] Ameli kalkhoran, S.M, Rabiei, K, Seyed Alizadeh, SM, Heravi, HM, Rouzpeykar, Y, (2022), Analyzing Impact of Intellectual Capital on Business Performance Using Structural Models Based on Customer Knowledge Management, Discrete Dynamics in Nature and Society, 7453565
[7] Fakhari, S., Pishghahi, A., Pourfathi, H., Farzin, H., & Bilehjani, E. (2021). A comparison between low-level laser therapy and intra-articular ozone injection in knee osteoarthritis treatment: A randomized clinical trial. Journal of Lasers in Medical Sciences, *12*, Article e44.
[8] Wijeysundera, D. N., Naik, J. S., & Beattie, W. S. (2003). Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: A meta-analysis. The American Journal of Medicine, *114*(9), 742–752.
[9] Bulow, N. M., Colpo, E., Pereira, R. P., Correa, E. F., Waczuk, E. P., Duarte, M. F., & Rocha, J. B. (2016). Dexmedetomidine decreases the inflammatory response to myocardial surgery under mini-cardiopulmonary bypass. Brazilian Journal of Medical and Biological Research, *49*(4), Article e4646.
[10]    Wang, X. W., Cao, J. B., Lv, B. S., Mi, W. D., Wang, Z. Q., Zhang, C., Wang, H. L., & Xu, Z. (2015). Effect of perioperative dexmedetomidine on the endocrine modulators of stress response: A meta-analysis. Clinical and Experimental Pharmacology and Physiology, *42*(8), 828–836.
[11]    Hashemian, M., Ahmadinejad, M., Mohajerani, S. A., & Mirkheshti, A. (2017). Impact of dexmedetomidine on hemodynamic changes during and after coronary artery bypass grafting. Annals of Cardiac Anaesthesia, *20*(2), 152–157.
[12]    Wu, H., Tang, J., Pan, J., Han, M., Cai, H., & Zhang, H. (2020). Effects of dexmedetomidine on stress hormones in patients undergoing cardiac valve replacement: A randomized controlled trial. BMC Anesthesiology, *20*(1), Article 142.
[13]    Zhou, H., Zhou, D., Lu, J., Wu, C., & Zhu, Z. (2019). Effects of pre-cardiopulmonary bypass administration of dexmedetomidine on cardiac injuries and the inflammatory response in valve replacement surgery with a sevoflurane post conditioning protocol: A pilot study. Journal of Cardiovascular Pharmacology, *74*(2), 91–97.
[14]    Dong, W., Li, X., Wang, X., Cheng, X., Kong, L., Guo, Z., & Jing, H. (2022). Influence of dexmedetomidine on cognitive function and inflammatory factors in rats and analysis of its molecular mechanism after cardiac surgery under cardiopulmonary bypass. Cellular and Molecular Biology (Noisy-le-Grand, France), *68*(2), 119–125.
[15]    Hussien, R. M., El Shafei, M. N., Ahmed, M. M., Abdelmoneim, W., Ghoneim, M. A., & Tolba, M. A. (2025). Effect of dexmedetomidine on stress-induced changes in hemodynamic and left ventricular function in coronary artery bypass grafting surgery: A randomized controlled trial. Journal of Cellular & Molecular Anesthesia, *10*(10).
[16]    Wald, E. L., Preze, E., Eickhoff, J. C., & Backer, C. L. (2011). The effect of cardiopulmonary bypass on the hypothalamic-pituitary-adrenal axis in children. Pediatric Critical Care Medicine, *12*(2), 190–196.
[17]    Bilehjani, E., Fakhari, S., Farzin, H., Tajlil, A., & Nader, N. D. (2024). Diagnosis and treatment of cardiovascular manifestations of COVID-19: A narrative review. Acta Cardiologica, *79*(3), 267–273.
[18]    Bekker, A., Haile, M., Kline, R., Didehvar, S., Babu, R., Martiniuk, F., & Urban, M. (2013). The effect of intraoperative infusion of dexmedetomidine on the quality of recovery after major spinal surgery. Journal of Neurosurgical Anesthesiology, *25*(1), 16–24.
[19]    Hohl, C. M., Kelly-Smith, C. H., Yeung, T. C., Sweet, D. D., Doyle-Waters, M. M., & Schulzer, M. (2010). The effect of a bolus dose of etomidate on cortisol levels, mortality, and health services utilization: A systematic review. Annals of Emergency Medicine, *56*(2), 105–113.
[20]    Albuzyad, S. S. and Jawad, M. K. (2025). A Systematic Review of Radiology and Radio Oncology Evaluations in Patients with Thoracic and Pelvic Cancers based on Radiological Images. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(1), 1-11.
[21]    Agha Mohammadi, D., Bilehjani, E., Farzin, H., Fakhari, S., & Naderpour, M. (2020). Effect of pressure on the Yinmen point in relief of pain after middle ear surgery: A randomized clinical trial. Anesthesiology and Pain Medicine, *10*(5), Article e103328.
[22]    Okuyama, K., Wada, K., Sakurada, S., Mizoguchi, H., Komatsu, H., Sora, I., Tamura, G., Ohkawara, Y., Takayanagi, M., & Ohno, I. (2010). The involvement of micro-opioid receptors in the central nervous system in the worsening of allergic airway inflammation by psychological stress in mice. International Archives of Allergy and Immunology, *152*(4), 342–352.
[23]    NazarI, M. Akhlaghi, F. Pourfathi Nematabad, H. (2025), Comparison of Postoperative nausea and vomiting prevalence in patients with routine NPO and NPO with clear fluids 2 hours before cataract surgery, Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1, 132-139
[24]    Duncan, D., Sankar, A., Beattie, W. S., & Wijeysundera, D. N. (2018). Alpha-2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery. Cochrane Database of Systematic Reviews, *2018*(3), Article CD004126.
[25]    Park, J. W., Chung, H. W., Lee, E. J., Jung, K. H., Paik, J. Y., & Lee, K. H. (2013). Alpha2-adrenergic agonists including xylazine and dexmedetomidine inhibit norepinephrine transporter function in SK-N-SH cells. Neuroscience Letters, *541*, 184–189.
[26]    Bilehjani, E., Nader, N., Farzin, H., Haghighate Azari, M., & Fakhari, S. (2020). The evaluation of factors affecting hemodynamic variability in mechanically ventilated patients after cardiac surgery. Anesthesiology and Pain Medicine, *10*(4), Article e101832.
 
Medicinal, Psychological, and Health Research Journal (MPHRJ)
Volume 2, Issue 5
September and October 2026
Pages 351-359

Home

Editorial Board

Guide for Authors

Submit Manuscript

Contact Us